NEW HAVEN, Conn. (WTNH) — With Connecticut’s COVID-19 positivity rate on the rise, there is new information on younger children potentially getting vaccinated and a therapeutic treatment children are eligible for if they have the virus.

Yale Medicine Dr. Rima Fawaz warns people not to become complacent about the spread and dangers of the virus.

“We should not let our guard down because we still are seeing COVID and probably it’s underreported because of the home testing at this point,” Fawaz said.

While children younger than five have a better tolerance to the virus than adults, they are still vulnerable.

The CDC reports 468 COVID-19 deaths in the U.S. in kids under five. That data was updated Sunday. That is more deaths of the youngest children than in the five to 11-year-old age range. The younger children are also hospitalized at a higher rate.

WEB EXTRA: Yale Medicine Dr. Rima Fawaz discusses COVID numbers climbing in Connecticut and gastrointestinal symptoms

Now COVID-19 vaccines for the youngest are delayed again, frustrating some parents who keep hearing the possible availability as a moving target since last fall.

“The timeline for the approval has been pushed a little bit to June, but I think in general, we advise toward vaccination to help protect younger kids and older patients and susceptible patients,” Fawaz said.

On Monday, the FDA granted the first full approval for treating COVID in children 28 days and older with the drug Remdesivir. This now makes babies through kids 11-years-old eligible. It is meant for kids hospitalized with COVID-19 or those at a high risk of severe COVID-19.

Fawaz advises people to pay attention to other symptoms of a COVID-19 infection. such as gastrointestinal issues.

“We are seeing more GI-related symptoms with omicron as compared to the Delta, which had more respiratory symptoms, although GI symptoms was also seen in the Delta variant symptoms.”